These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 3350412

  • 1. [Hypotensive effect of furosemide and verapamil in the elderly].
    Oren S, Viskoper R, Laszt A, Modan M.
    Harefuah; 1988 Jan 01; 114(1):9-12. PubMed ID: 3350412
    [No Abstract] [Full Text] [Related]

  • 2. [Action of verapamil as a hypotensive agent - analysis of the arterial pressure curve in the cycloergometric test].
    Candau LA, Tasca R, Carvalho DM, Scherr C.
    Arq Bras Cardiol; 1981 Mar 01; 36 Suppl 1():18-23. PubMed ID: 7325859
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of the hypotensive effect induced by a combination of furosemide and reserpine].
    Oldrini R.
    Clin Ter; 1969 Nov 15; 51(3):245-56. PubMed ID: 5407319
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The long-term management of hypertension with verapamil.
    Lewis GR.
    Clin Exp Pharmacol Physiol Suppl; 1982 Nov 15; 6():107-12. PubMed ID: 6811175
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment of arterial hypertension with verapamil.
    Wigler I, Peer G, Soferman G, Blum M, Aviram A.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar 15; 22(3):162-6. PubMed ID: 6715085
    [Abstract] [Full Text] [Related]

  • 7. Assessment of the antihypertensive effect of a retard preparation of furosemide (Lasix retard) in monotherapy of mild hypertension.
    Keoplung M.
    J Med Assoc Thai; 1981 Dec 15; 64(12):624-9. PubMed ID: 6153030
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Use of isoptin SR-240 in treatment of hypertension].
    Knypl K, Brym E, Wacławek-Maczkowska J.
    Wiad Lek; 1993 Dec 15; 46(23-24):898-901. PubMed ID: 7900385
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA, Chou TC, Lin KC.
    J Hum Hypertens; 1994 Apr 15; 8(4):273-8. PubMed ID: 8021907
    [Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of the effect of verapamil in hypertensive patients].
    Gelman A, de Albuquerque EM, Reynaldo Stella S, Draibe SA, Ajzen H.
    Arq Bras Cardiol; 1983 Jan 15; 40(1):69-71. PubMed ID: 6351814
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Verapamil 240 mg--effective blood pressure reduction by a single dose?].
    Edmonds D, Baumgart P, Tenschert W, Vetter W, Vetter H.
    Schweiz Rundsch Med Prax; 1985 May 07; 74(19):507-9. PubMed ID: 4012134
    [No Abstract] [Full Text] [Related]

  • 18. [Efficacy of verapamil in severe hypertension and hypertensive emergencies].
    Zanolli MB, Herdoiza GL, Padolan E, Mulinari AS, Lassitte A, Branco BP, Marks SC, Rocha de Carvalho JG.
    Arq Bras Cardiol; 1982 Sep 07; 39(3):193-6. PubMed ID: 7186365
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN, Barter C, Adam WR, Doyle AE.
    J Cardiovasc Pharmacol; 1982 Sep 07; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.